Vimarsana
Biggest News Aggregation in the World

Intj Pharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intj Pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intj Pharm Today - Breaking & Trending Today

Is a Digital Detox the Answer to Technostress? - Vimarsana News

Is a Digital Detox the Answer to Technostress?

Many studies have indicated that overt use of information technology leads to technostress, which is defined as “stress or psychosomatic illness caused by working with computer technology on a daily basis."

Global Prevalence of Sleep Disorders Demands a Team-Based Approach - Vimarsana News

Global Prevalence of Sleep Disorders Demands a Team-Based Approach

Because medications to treat these conditions are often controlled substances, including pharmacists on the multidisciplinary team (MDT) is invaluable.

Fagron launches excipients line DiluCap - making capsule formulation easier and more reliable - Vimarsana News

Fagron launches excipients line DiluCap - making capsule formulation easier and more reliable

Fagron, the leading global player in pharmaceutical compounding, launches DiluCap, a new line of six excipients for compounding pharmacies allowing for easier and faster capsule formulation. Choosing the right excipient is paramount for the adequate clinical performance of a robust dosage form. This choice must be ...

Nanomerics announces patents granted in the US, Europe and Japan and two key publications on the ocular use of its Molecular Envelope Technology - Vimarsana News

Nanomerics announces patents granted in the US, Europe and Japan and two key publications on the ocular use of its Molecular Envelope Technology

Nanomerics announces patents granted in the US, Europe and Japan and two key publications on the ocular use of its Molecular Envelope Technology ACCESSWIRE LONDON, UK / ACCESSWIRE / May 24, 2021 / Nanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced the Company had been granted patent protection in multiple territories for the use of its Molecular Envelope Technology (MET) for ocular applications. These patents have been granted by the European Patent Office (EP3215119 ), the United States Patent and Trademark Office (US10987304) and the Japan Patent...